Ginkgo Bioworks Holdings's market cap is currently ―. The company's EPS TTM is $-0.459; its P/E ratio is -1.90; Ginkgo Bioworks Holdings is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 55.43M	$ 80.57M	$ 80.70M	$ 98.28M	$ 66.40M
Gross Profit	$ 49.41M	$ 62.47M	$ 58.33M	$ 236.47M	$ 41.74M
EBIT	$ -317.93M	$ -187.60M	$ -219.43M	$ -201.98M	$ -653.02M
EBITDA	$ -272.81M	$ -169.38M	$ -238.39M	$ -235.05M	$ -643.51M
Net Income Common Stockholders	$ -302.89M	$ -173.31M	$ -204.97M	$ -8.14M	$ -669.05M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.05B	$ 1.11B	$ 1.21B	$ 1.32B	$ 1.30B
Total Assets	$ 2.03B	$ 2.29B	$ 2.42B	$ 2.54B	$ 1.87B
Total Debt	$ 403.66M	$ 410.94M	$ 404.10M	$ 413.26M	$ 59.84M
Net Debt	$ -645.58M	$ -694.85M	$ -801.99M	$ -902.54M	$ -1.24B
Total Liabilities	$ 773.71M	$ 774.27M	$ 809.62M	$ 803.04M	$ 430.96M
Stockholders Equity	$ 1.26B	$ 1.52B	$ 1.62B	$ 1.74B	$ 1.43B
Cash Flow	-
Free Cash Flow	$ -77.86M	$ -84.76M	$ -109.41M	-	$ -41.77M
Operating Cash Flow	$ -73.55M	$ -73.53M	$ -90.58M	-	$ -28.30M
Investing Cash Flow	$ -3.38M	$ -11.22M	$ -19.41M	-	$ -46.49M
Financing Cash Flow	$ -315.00K	$ -1.38M	$ -888.00K	-	$ -450.00K

Currency in USD

Ginkgo Bioworks Holdings Earnings and Revenue History

Income Statement >

Ginkgo Bioworks Holdings Debt to Assets

Balance Sheet >

Ginkgo Bioworks Holdings Cash Flow

Cash Flow >

Ginkgo Bioworks Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing